Rheumatic fever and rheumatic heart disease are still major causes of disease in the developing world today. Diagnosis and prevention, particularly secondary prophylaxis, will become even more important as increased urbanization, with greater population pressure and economic problems, increase the prevalence. The number of children and young adults in their most crucial years of life who would avoid chronic disease and death would more than repay the investment of time and resources.
Get full access to this article
View all access options for this article.
References
1.
NordetWHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries; report from phase 1 (1986–90). Bull WHO1992; 70: 213–18
2.
KumarR. Controlling rheumatic heart disease in developing countries. World Health Forum1995; 16: 47–51
3.
KaplanEL. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century: influences and dynamics of populations and pathogens — a failure to realize prevention?Circulation1993; 88: 1964–72
4.
MajeedHA. Acute rheumatic fever. Med Int1993; 21: 491–6
5.
DajaniAS and the AHA Writing Group. Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992. Circulation1993; 87: 302–7
6.
ThakurJSNegiPCAhluwaliaSKVaidyaNK. Epidemiological survey of rheumatic heart disease among school children in the Shimla Hills of northern India: prevalence and risk factors. J Epidemiol Community Health1996; 50: 62–7
BerriosXdel CampoEWilsonCBlasquezJMoralesAQuesneyF. Acute rheumatic fever in the southeastern metropolitan area of Santiago, Chile 1976–1981. Bull Pan Am Health Org1984; 18: 389–96
9.
EissaAMel TayebSNourNM. HLA antigen frequencies in children with cardiac disease in Cairo. J Trop Pediatr1991; 37: 226–31
10.
MohsE. Effectiveness of prevention in Costa Rica. Paed Inf Dis1982; 1: 212–16
11.
ShresthaNKPadmavatiS. Prevalence of rheumatic heart disease in Delhi schoolchildren. Indian J Med Res1979; 69: 821–33
12.
EisenbergMJ. Rheumatic heart disease in the developing world: prevalence, prevention, and control. Eur Heart J1993; 14: 122–8
13.
NeilsonGStreatfieldRWWestM, Rheumatic fever and chronic rheumatic heart disease in Yarrabah aboriginal community, north Queensland. Med J Aust1993; 158: 316–18
14.
BachJFChalonsSForierE, 10 year educational programme aimed at rheumatic fever in 2 French Caribbean islands. Lancet1996; 347: 644–8
15.
StrasserT. Cost effective control of rheumatic fever in the community. Health Policy1985; 5: 159–64
16.
WHO. The use of essential drugs. Seventh report of the WHO Expert Committee. WHO Techn Rep Ser1997; 867: 1–74
17.
OakleyCM. Management of valvular stenosis. Curr Opinion Cardiol1995; 10: 117–23
